Yield10 Bioscience, Inc. Common Stock
YTEN
YTEN was delisted on the 15th of May, 2024.
13 hedge funds and large institutions have $6.13M invested in Yield10 Bioscience, Inc. Common Stock in 2014 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 2 closing their positions.
7% less funds holding
Funds holding: 14 → 13 (-1)
37% less capital invested
Capital invested by funds: $9.75M → $6.13M (-$3.62M)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Stifel Financial
St. Louis,
Missouri
|
+$56.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$338K |
| 2 |
FA
FCG Advisors
Chatham,
New Jersey
|
-$113K |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$78K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$38K |
| 5 |
Group One Trading
Chicago,
Illinois
|
-$6K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
MCM
26
Manchester Capital Management
Manchester,
Vermont
| $1K | – | – | – |
|
27
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| $1K | – | – | – |
|
|
PSC
28
Prentiss Smith & Co
Brattleboro,
Vermont
| $1K | – | – | – |
|
29
Royal Bank of Canada
Toronto,
Ontario, Canada
| $1K | – | – | – |
|
|
U
30
UBS
Zurich,
Switzerland
| $1K | – | – | – |
|
31
Wells Fargo
San Francisco,
California
| $1K | – | – | – |
|
32
BNP Paribas Financial Markets
Paris,
France
| $471 | – | – | – |
|
|
WEC
33
Winslow Evans & Crocker
Boston,
Massachusetts
| $174 | – | – | – |
|
|
BFA
34
BlackRock Fund Advisors
San Francisco,
California
| – | -$78K | -1 | Closed |
|
|
35
Citadel Advisors
Miami,
Florida
| – | -$38K | -1 | Closed |
|
36
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | -$1K | – | – |
|
|
37
Group One Trading
Chicago,
Illinois
| – | -$6K | – | – |
|
YTEN Hedge Fund Activity: Q2 2014 in Review
13 of the 3,481 institutional investors tracked by Wall St. Rank reported a position in Yield10 Bioscience, Inc. Common Stock (YTEN) for Q2 2014, worth a combined $6.13M — down 37% from $9.75M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of YTEN and 1 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 0 added.
The largest buyer was Stifel Financial, opening a new position worth an estimated $56.3K. The largest seller was Fidelity Investments, cutting an estimated $338K.
- 13 institutional investors held Yield10 Bioscience, Inc. Common Stock (YTEN) as of Q2 2014, down from 14 in Q1 2014.
- Funds reported $6.13M of Yield10 Bioscience, Inc. Common Stock stock for Q2 2014, down 37% quarter-over-quarter.
- 1 fund opened new Yield10 Bioscience, Inc. Common Stock positions in Q2 2014 and 2 closed out, a net change of -1 holder.
- The largest Yield10 Bioscience, Inc. Common Stock buyer in Q2 2014 was Stifel Financial, an estimated $56.3K added.
- The largest Yield10 Bioscience, Inc. Common Stock seller in Q2 2014 was Fidelity Investments, an estimated $338K sold.
Based on aggregated 13F filings for Q2 2014.